author-photo

Naveed Wagle

University of Southern California

26

Papers

245

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

CTNI-46. PHASE I OPEN-LABEL, SINGLE-CENTER, DOSE ESCALATION STUDY (NCT02423525) OF PULSATILE AFATINIB IN PATIENTS WITH BRAIN CANCER

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Successful and durable response of primary CNS T-cell lymphoma to upfront temozolomide monotherapy.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
CTNI-32. CASE SERIES OF BRAF INHIBITORS FOR THE TREATMENT OF BRAFV600E GLIOBLASTOMA

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma.

2021
Show All
- Source
- Cite
- Save
Citations (1)
DDRE-09. MULTI-INSTITUTION RETROSPECTIVE EXPERIENCE WITH LENVATINIB FOR PROGRESSIVE MALIGNANT GLIOMA

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.

2020 Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Characterization of molecular pathways for targeting therapy in glioblastoma

2020 Chinese clinical oncology
Show All
- Source
- Cite
- Save
Citations (1)
MNGI-05. COMBINED MULTIMODAL TREATMENT REGIMEN IN RECURRENT MENINGIOMAS

2019 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract CT064: Intranasal brain delivery using NEO100 for recurrent glioblastoma

2019 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity

2018 Journal of Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (48)